This confirms prior findings from cross-sectional studies, which have also reported a higher incidence of insulin use among individuals with more advanced stages of CKD (Busch et al., 2016; Gor et al., 2019; Grandfils et al., 2013). This evidence concerns the gene INS and chronic kidney disease.